nj_start26DPP01283
Open
T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services
- Response deadline
- Oct 27, 2026 Due in 69 days
- Date posted
- —
- Source
- Open notice
Description
T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services
Classifications
- NAICS269
Documents (6)
- T3165 26DPP01283 ATTACHMENT 1 Combined State of New Jersey Standard Terms and Conditions 6.3.25application/octet-stream;charset=UTF-8384 KBNot yet available
- T3165 26DPP01283 Bid Solicitation 8.20.2026application/octet-stream;charset=UTF-8227 KBNot yet available
- T3165 26DPP01283 State-Supplied Price Sheet 8.20.26application/octet-stream;charset=UTF-820 KBNot yet available
- T3165 26DPP01283 ATTACHMENT 2 Standard Procurement Forms Packet 8.20.26application/octet-stream;charset=UTF-8894 KBNot yet available
- T3165 26DPP01283 ATTACHMENT 3 Specification Conformance Form 8.20.26application/octet-stream;charset=UTF-891 KBNot yet available
- T3165 26DPP01283 ATTACHMENT 4 Bidder Data Sheet 8.20.26application/octet-stream;charset=UTF-8272 KBNot yet available
Contacts
Similar contracts
- IDVA-LaSalle Emergency Pharmacy -EMERGENCY FINAL COSTSILDue Jul 9, 2020
- Emergency Final Cost JPMC Drugs and PharmaceuticalsILDue Apr 25, 2022
- JPMC MMCAP Infuse Coop purchase for Distribution of Vaccines and Vaccine-related ProductsILDue May 21, 2024
- JPMC MMCAP Pharmaceuticals and Over the Counter ProductsILDue Mar 15, 2023
- JPMC MMCAP Male and Female CondomsILDue Apr 1, 2022
- JPMC MMCAP RFP# MS2005001 Generic Multisource Pharmaceuticals and Over the Counter ProductsILDue Mar 5, 2025